Nanovibronix PE Ratio 2014-2024 | NAOV
Current and historical p/e ratio for Nanovibronix (NAOV) from 2014 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Nanovibronix PE ratio as of October 09, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Nanovibronix PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-10-09 | 0.58 | 0.00 | |
| 2024-06-30 | 0.70 | $-1.29 | 0.00 |
| 2024-03-31 | 0.90 | $-1.69 | 0.00 |
| 2023-12-31 | 1.15 | $-2.13 | 0.00 |
| 2023-09-30 | 1.97 | $-1.74 | 0.00 |
| 2023-06-30 | 3.43 | $-2.32 | 0.00 |
| 2023-03-31 | 3.43 | $-2.47 | 0.00 |
| 2022-12-31 | 5.04 | $-1.80 | 0.00 |
| 2022-06-30 | 12.60 | $-7.00 | 0.00 |
| 2022-03-31 | 23.20 | $-6.20 | 0.00 |
| 2021-12-31 | 20.80 | $-5.40 | 0.00 |
| 2021-09-30 | 41.20 | $-5.40 | 0.00 |
| 2021-06-30 | 17.02 | $-2.20 | 0.00 |
| 2021-03-31 | 20.40 | $-6.00 | 0.00 |
| 2020-12-31 | 15.28 | $-8.60 | 0.00 |
| 2020-09-30 | 14.01 | $-12.00 | 0.00 |
| 2020-06-30 | 45.00 | $-12.40 | 0.00 |
| 2020-03-31 | 43.00 | $-9.00 | 0.00 |
| 2019-12-31 | 57.00 | $-9.60 | 0.00 |
| 2019-09-30 | 50.00 | $-14.20 | 0.00 |
| 2022-09-30 | 9.20 | $-15.40 | 0.00 |
| 2019-06-30 | 58.00 | $-19.00 | 0.00 |
| 2019-03-31 | 81.00 | $-18.40 | 0.00 |
| 2018-12-31 | 72.42 | $-12.80 | 0.00 |
| 2018-09-30 | 91.80 | $-14.40 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.002B | $0.002B |
| NanoVibronix, Inc. is a medical device company. The Company's products include WoundShield(TM), a patch-based therapeutic ultrasound device which facilitates tissue regeneration and wound healing; PainShield(R), a disposable patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures; UroShield(TM), an ultrasound-based product which is designed to prevent biofilm in urinary catheters; NanoVibronix, lightweight pump which allow contamination-free handling of infected wound exudate and enhanced patient mobility. NanoVibronix, Inc. is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.911B | 27.44 |
| Intuitive Surgical (ISRG) | United States | $174.259B | 98.67 |
| Alcon (ALC) | Switzerland | $47.569B | 33.49 |
| IQVIA Holdings (IQV) | United States | $41.708B | 23.64 |
| Edwards Lifesciences (EW) | United States | $40.975B | 26.26 |
| IDEXX Laboratories (IDXX) | United States | $39.066B | 46.99 |
| DexCom (DXCM) | United States | $27.899B | 39.78 |
| STERIS (STE) | Ireland | $22.401B | 26.14 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.114B | 0.00 |
| Waters (WAT) | United States | $21.182B | 31.58 |
| Hologic (HOLX) | United States | $18.610B | 20.23 |
| Sysmex ADR (SSMXY) | Japan | $12.241B | 38.39 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.783B | 13.21 |
| Teleflex (TFX) | United States | $11.045B | 17.17 |
| Globus Medical (GMED) | United States | $9.538B | 26.68 |
| Penumbra (PEN) | United States | $7.674B | 79.66 |
| Masimo (MASI) | United States | $7.633B | 40.88 |
| Glaukos (GKOS) | United States | $7.120B | 0.00 |
| TransMedics (TMDX) | United States | $4.576B | 195.97 |
| Integer Holdings (ITGR) | United States | $4.350B | 25.43 |
| PROCEPT BioRobotics (PRCT) | United States | $3.850B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.828B | 16.59 |
| Elekta AB (EKTAY) | Sweden | $2.565B | 20.90 |
| Tandem Diabetes Care (TNDM) | United States | $2.561B | 0.00 |
| Veracyte (VCYT) | United States | $2.452B | 152.00 |
| Inari Medical (NARI) | United States | $2.429B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.397B | 14.91 |
| RxSight (RXST) | United States | $1.825B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.404B | 6.40 |
| Artivion (AORT) | United States | $1.070B | 98.19 |
| OPKO Health (OPK) | United States | $1.046B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.032B | 18.41 |
| Pulse Biosciences (PLSE) | United States | $0.965B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.746B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.673B | 17.00 |
| IRadimed (IRMD) | United States | $0.626B | 33.83 |
| AxoGen (AXGN) | United States | $0.602B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.576B | 0.00 |
| SiBone (SIBN) | United States | $0.535B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.439B | 0.00 |
| Paragon 28 (FNA) | United States | $0.439B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 10.27 |
| ClearPoint Neuro (CLPT) | United States | $0.335B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.325B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.285B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.247B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.236B | 0.00 |
| Inogen (INGN) | United States | $0.213B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.185B | 12.96 |
| NeuroPace (NPCE) | United States | $0.178B | 0.00 |
| Accuray (ARAY) | United States | $0.176B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.176B | 0.00 |
| Nevro (NVRO) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.166B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.157B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.118B | 0.00 |
| 908 Devices (MASS) | United States | $0.117B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.112B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.104B | 15.41 |
| EDAP TMS S.A (EDAP) | France | $0.097B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.043B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.041B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.038B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.037B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.028B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| Spectral AI (MDAI) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |